Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 1.8T | 1.8T | 1.8T | 1.7T |
Cost of revenue | 1.5T | 1.5T | 1.5T | 1.5T |
Gross profit | 289.3B | 298.6B | 274.1B | 228.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 149.0B | 276.1B | 158.3B | 131.7B |
Other operating expenses | 20.2B | 10.9B | 7.0B | 5.7B |
Operating income | 142.0B | 26.8B | 117.4B | 94.4B |
Non operating interest income | ||||
Income | 12.1B | 29.4B | 8.6B | 28.6B |
Expense | 2.2B | 8.5B | 6.0B | 5.5B |
Other income expense | — | — | — | — |
Pretax income | 147.5B | 41.1B | 118.4B | 129.3B |
Tax provision | -1.3B | 19.9B | 25.5B | 36.5B |
Net income | 148.8B | 21.2B | 92.9B | 92.7B |
Basic EPS | — | 2.2 | 7.0 | 28.5 |
Diluted EPS | — | 2.2 | 7.0 | 28.5 |
Basic average shares | — | 3.0B | 12.0B | 3.0B |
Diluted average shares | — | 3.0B | 12.0B | 3.0B |
EBITDA | 243.7B | 142.8B | 218.9B | 227.3B |
Net income from continuing op. | 147.5B | 41.1B | 118.4B | 129.3B |
Minority interests | -11.6B | -14.5B | -9.4B | -7.3B |
Preferred stock dividends | 0 | 0 | 0 | 0 |